For research use only. Not for use in humans.

Anti-mouse L-Selectin (CD62L)-InVivo

Synonyms: CD3E, IL3RA Clone No.:Mel-14

Anti-mouse L-Selectin (CD62L)-InVivo reacts with mouse CD62L also known as L-selectin and MEL-14. CD62L is a 76 kDa glycoprotein and a member of the selectin family.

Anti-mouse L-Selectin (CD62L)-InVivo

Click to purchase the isotype control of Anti-mouse L-Selectin (CD62L)-InVivo

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet
99

Product Details

Molecular Weight 150 kDa
Clone Mel-14
Isotype Rat IgG2a, κ
Application in vivo CD62L neutralization.
Source CHO
Purification Protein G
Sterility 0.2 μM filtered
Formulation PBS, pH 7.0. Contains no stabilizers or preservatives
Murine Pathogen Screening Panel all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT06034535 RECRUITING Hematopoietic Organs; Disorder Hong Kong Children's Hospital 2023-09-01 PHASE2
NCT03836690 UNKNOWN Lymphoma; Leukemia; Myeloma; Myelodysplastic Syndromes; Severe Aplastic Anemia; Primary Immune Deficiency; Graft Vs Host Disease University College, London 2019-10-21 PHASE1
NCT02062359 TERMINATED Drug: Aldesleukin|Drug: Cyclophosphamide|Drug: Fludarabine Metastatic Cancer; Metastatic Melanoma National Cancer Institute (NCI) 2014-02 PHASE2

(data from https://clinicaltrials.gov, updated on 2025-09-15)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.